161 related articles for article (PubMed ID: 26972492)
1. Sildenafil ameliorates left ventricular T-tubule remodeling in a pressure overload-induced murine heart failure model.
Huang CK; Chen BY; Guo A; Chen R; Zhu YQ; Kutschke W; Hong J; Song LS
Acta Pharmacol Sin; 2016 Apr; 37(4):473-82. PubMed ID: 26972492
[TBL] [Abstract][Full Text] [Related]
2. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil ameliorates right ventricular early molecular derangement during left ventricular pressure overload.
Imai Y; Kariya T; Iwakiri M; Yamada Y; Takimoto E
PLoS One; 2018; 13(4):e0195528. PubMed ID: 29621314
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo.
Blanton RM; Takimoto E; Lane AM; Aronovitz M; Piotrowski R; Karas RH; Kass DA; Mendelsohn ME
J Am Heart Assoc; 2012 Oct; 1(5):e003731. PubMed ID: 23316302
[TBL] [Abstract][Full Text] [Related]
6. T-tubule remodeling during transition from hypertrophy to heart failure.
Wei S; Guo A; Chen B; Kutschke W; Xie YP; Zimmerman K; Weiss RM; Anderson ME; Cheng H; Song LS
Circ Res; 2010 Aug; 107(4):520-31. PubMed ID: 20576937
[TBL] [Abstract][Full Text] [Related]
7. Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.
Rai N; Veeroju S; Schymura Y; Janssen W; Wietelmann A; Kojonazarov B; Weissmann N; Stasch JP; Ghofrani HA; Seeger W; Schermuly RT; Novoyatleva T
Biomed Res Int; 2018; 2018():3293584. PubMed ID: 29511676
[TBL] [Abstract][Full Text] [Related]
8. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
9. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
11. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
13. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
14. The immediate effect of sildenafil on right ventricular function in patients with heart failure measured by cardiac magnetic resonance: a randomized control trial.
Fernandes AM; Andrade AC; Barroso ND; Borges IC; Carvalho-Andrade D; Rodrigues Junior ES; Guimarães LC; Durães AR; Borges SM; Aras Junior R
PLoS One; 2015; 10(3):e0119623. PubMed ID: 25793988
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload.
Nagayama T; Hsu S; Zhang M; Koitabashi N; Bedja D; Gabrielson KL; Takimoto E; Kass DA
J Am Coll Cardiol; 2009 Jan; 53(2):207-15. PubMed ID: 19130990
[TBL] [Abstract][Full Text] [Related]
16. PDE5 inhibitors protect against post-infarction heart failure.
Li N; Yuan Y; Li S; Zeng C; Yu W; Shen M; Zhang R; Li C; Zhang Y; Wang H
Front Biosci (Landmark Ed); 2016 Jun; 21(6):1194-210. PubMed ID: 27100500
[TBL] [Abstract][Full Text] [Related]
17. The impact of phosphodiesterase-5 inhibition or angiotensin-converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload.
Tykvartova T; Miklovic M; Kotrc M; Skaroupkova P; Kazdova L; Trnovska J; Skop V; Kolar M; Novotny J; Melenovsky V
Pharmacol Res Perspect; 2024 Feb; 12(1):e1172. PubMed ID: 38284173
[TBL] [Abstract][Full Text] [Related]
18. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circ Heart Fail; 2011 Jan; 4(1):8-17. PubMed ID: 21036891
[TBL] [Abstract][Full Text] [Related]
19. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 5 Associates With β2 Adrenergic Receptor to Modulate Cardiac Function in Type 2 Diabetic Hearts.
West TM; Wang Q; Deng B; Zhang Y; Barbagallo F; Reddy GR; Chen D; Phan KS; Xu B; Isidori A; Xiang YK
J Am Heart Assoc; 2019 Aug; 8(15):e012273. PubMed ID: 31311394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
